Research Article
[Retracted] The Role of C-Reactive Protein in the Prognosis of Prostate Cancer: A Meta-Analysis
Table 2
Basic information of the included literature.
| Number | Study | Year | Country/region | Age median | Study type | Number of patients | Prostate-specificantigen level |
| 1 | Ito et al. [13] | 2011 | Japan | 70 | Prospective | 80 | 40 ng/mL | 2 | Yamada et al. [14] | 2019 | Japan | 75 | Retrospective | 196 | 397.15 ng/mL | 3 | Merriel et al. [15] | 2021 | England | 74.38 | Retrospective | 10 901 | — | 4 | Prins et al. [16] | 2012 | USA | 71.9 | Prospective | 119 | 80.8 (0.8–2113) ng/mL | 5 | Beer et al. [17] | 2008 | USA | 69.5 | Prospective | 160 | 107 (4–6288) ng/mL | 6 | Hall et al. [18] | 2013 | USA | 64 | Retrospective | 206 | 14.7 [0.48–166] ng/mL | 7 | Ilktac et al. [19] | 2021 | Turkey | 66.85 | Retrospective | 149 | — | 8 | Stikbakke et al. [20] | 2019 | Norway | 71.7 | Prospective | 7356 | 14.3 μg/L | 9 | Stark et al. [21] | 2009 | USA | 59.4 | Prospective | 22071 | — | 10 | Xu et al. [22] | 2015 | China | 65 | Retrospective | 135 | 80 ng/mL | 11 | Benli et al. [23] | 2018 | Turkey | 67.6 | Retrospective | 231 | 6.87 ± 7.27 (PCa) and 0.91 ± 0.6 ng/dl (control) | 12 | Tulloch-Reid [10] | 2017 | Africa | 65.4 | Retrospective | 481 | — |
|
|